BMS986205

BMS-986205 · Bristol Myers Squibb

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for BMS986205, covering 2025-06-06 to 2025-06-06. Get the full timeline:

Most recent: Clinical Trial Update: Nivolumab and BMS986205 in Treating Patients With Stage II-IV Squamous Cell Cancer of the Head and Neck [Phase 2]